Insights from 2024 ESMO GI Annual Meeting
ESMO GI 2024 Insights: DEEPER Trial - m-FOLFOXIRI + Cetuximab vs. Bevacizumab in Right-Sided/BRAF Mutant mCRC
By
Insights from 2024 ESMO GI Annual Meeting
FEATURING
Yu Sunakawa
By
Insights from 2024 ESMO GI Annual Meeting
FEATURING
Yu Sunakawa
Login to view comments.
Click here to Login
